2024-11-19 03:27:16
RemeGen Announces Preliminary Results of Phase III Confirmatory Study of Telitacicept for Treatment of Systemic Lupus Erythematosus (SLE) in China
Corporate/ 2023-07-24
RemeGen Announces Preliminary Results of...

YANTAI,China,Sept. 19,2022-- RemeGen Co.,Ltd. ("RemeGen" or "the Company") (9995.HK,SHA: 688331),a commercial-stage biot...

Special interview with Dr. Patrick Yu-Wai-Man on International LHON Awareness Day
Health/ 2023-07-22
Special interview with Dr. Patrick Yu-Wa...

WUHAN,China and SAN DIEGO,Sept. 19,2022--September 19th is International LHON Awareness Day.LHON is a debilitating disease that leads to qui...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release